[ad_1]
IVOSKIN launched its ‘Intensive Cica Repair Cream,’ formulated by biomedical researcher Eunbi Ko from the Korea Advanced Institute of Science and Technology, bringing unprecedented scientific rigor to the skincare industry. The cream targets atopic dermatitis with 85% naturally derived ingredients, including Centella Asiatica, madecassoside, and ceramides, addressing the specific pathological mechanisms of chronic skin conditions.
Ko’s personal battle with severe dermatitis drove the evidence-based formulation approach, investing over 35,000 hours in development focused on reducing inflammatory markers IL-1 and IL-8 through clinical testing. The product bridges the gap between cosmetic skincare and medical-grade dermatological solutions, offering consumers scientifically backed alternatives to traditional treatments.
This launch represents the growing trend of researcher-founded beauty brands that prioritize clinical efficacy over marketing claims, appealing to consumers who demand transparency and proven results in their skincare routines.
Image Credit: IVOSKIN
[ad_2]
Source link